Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron

Zhen Cui, Pan Liu, Nan Wang and 20 more

Cell · 2022 · CC BY

doi:10.1016/j.cell.2022.01.019

Abstract

The SARS-CoV-2 Omicron variant with increased fitness is spreading rapidly worldwide. Analysis of cryo-EM structures of the spike (S) from Omicron reveals amino acid substitutions forging interactions that stably maintain an active conformation for receptor recognition. The relatively more compact domain organization confers improved stability and enhances attachment but compromises the efficiency of the viral fusion step. Alterations in local conformation, charge, and hydrophobic microenvironments underpin the modulation of the epitopes such that they are not recognized by most NTD- and RBD-antibodies, facilitating viral immune escape. Structure of the Omicron S bound with human ACE2, together with the analysis of sequence conservation in ACE2 binding region of 25 sarbecovirus members, as well as heatmaps of the immunogenic sites and their corresponding mutational frequencies, sheds light on conserved and structurally restrained regions that can be used for the development of broad-spectrum vaccines and therapeutics.

References 59

1.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
2.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
3.
New tools for automated high-resolution cryo-EM structure determination in RELION-3 · 2018
No notice
4.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
5.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
6.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
7.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
8.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
9.
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 · 2020
No notice
10.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
11.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
12.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
13.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
14.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
15.
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies · 2020
No notice
16.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
17.
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody · 2020
No notice
18.
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding · 2020
No notice
19.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
20.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
21.
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants · 2020
No notice
22.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
23.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
24.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
25.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
26.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
27.
The antigenic anatomy of SARS-CoV-2 receptor binding domain · 2021
No notice
28.
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera · 2021
No notice
29.
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England · 2021
No notice
30.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
31.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
32.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
33.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
34.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
35.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
36.
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity · 2021
No notice
37.
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants · 2021
No notice
38.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
39.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
40.
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion · 2021
No notice

All 59 references

Cited by papers we hold 12

Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting · 2023
No notice
Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455–456 synergistically enhances antibody evasion and ACE2 binding · 2023
No notice
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies · 2023
No notice
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses · 2022
Not checked
SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis · 2022
Not checked
Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain · 2022
Not checked
Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors · 2022
No notice
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection · 2022
No notice
SARS-CoV-2 Omicron variant: recent progress and future perspectives · 2022
No notice
Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events · 2022
No notice
Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape · 2022
No notice
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution · 2022
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.